Hepatitis News

Officials confirm ninth case of hepatitis C

Las Vegas Review Journal Jul 24 2008 12:32AM GMT

Genelabs, Taiwan company collaborate on hepatitis C research

East Bay Business Journal Jul 23 2008 10:26PM GMT

Judge OKs emotional distress in hepatitis case

Reno Gazette-Journal Jul 23 2008 9:23PM GMT

Genelabs, China companies collaborate on hepatitis C research

Ein News Jul 23 2008 9:12PM GMT

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

Nature Jul 23 2008 9:04PM GMT

Genelabs, Taiwan company collaborates on hepatitis C research

Ein News Jul 23 2008 8:54PM GMT

Genelabs, Taiwan company collaborate on hepatitis C research

Ein News Jul 23 2008 8:53PM GMT

Genelabs, Taiwan company collaborate on hepatitis C research

San Jose Business Journal Jul 23 2008 7:39PM GMT

Genelabs inks hepatitis research deal with Taiwan

Ein News Jul 23 2008 7:15PM GMT

Genelabs inks hepatitis research deal with Taiwan

Biz Journals Jul 23 2008 6:26PM GMT

Hepatitis Updates and Commentary

Natalie Cole Optimistic About Her Battle with Hepatitis C
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus....

Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....

Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...

Popular Illegal Drug Extra Harmful with HCV
Scientists have found a popular street drug worsens Hepatitis C infection in two worrisome ways....

Hep C Long-Term Management Strategies
Since only about half of those on combination therapy beat Hepatitis C, the remaining people must strive to prevent their liver disease from progressing. Thus far, a liver wellness approach is a safer, more effective way to remain healthy compared...

Good News for Non-Responders to HCV Combination Therapy
A Phase 3 trial evaluating ZADAXIN® (thymalfasin) as a potential third component for Hepatitis C traditional combination therapy has just been completed. Although the data is currently being analyzed and won't be available until later in the year, the lead...

Purer, Less Costly Interferon for Hepatitis C and B Treatment
The Taiwan-based biopharmaceutical company PharmaEssentia Corp. is testing P1101, its third-generation PEG-interferon-alpha drug candidate. Because it is a longer-lasting, purer interferon that is less costly to produce, P1101 could enhance the treatment options for Hepatitis C and B....

New Technology May Help Treat Hepatitis
While pharmaceutical companies are racing to find safer, more effective treatments for viral Hepatitis C and B, physicists from Arizona have a unique perspective on accomplishing the same goal. Learn how these scientists believe the virus could be rendered harmless...